Compare · ATR vs NCL
ATR vs NCL
Side-by-side comparison of AptarGroup Inc. (ATR) and Northann Corp. (NCL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ATR and NCL operate in Plastic Products (Industrials), so they compete in similar markets.
- ATR is the larger of the two at $7.90B, about 924.7x NCL ($8.5M).
- NCL has been more active in the news (4 items in the past 4 weeks vs 3 for ATR).
- ATR has more recent analyst coverage (18 ratings vs 0 for NCL).
- Company
- AptarGroup Inc.
- Northann Corp.
- Price
- $124.48+0.22%
- $0.16-3.42%
- Market cap
- $7.90B
- $8.5M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Plastic Products
- Plastic Products
- Exchange
- NYSE
- AMEX
- IPO
- 2023
- News (4w)
- 3
- 4
- Recent ratings
- 18
- 0
AptarGroup Inc.
AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active packaging products. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup, Inc. has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. The company was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Latest ATR
- Aptar Announces CE Marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine Developers
- Deutsche Bank initiated coverage on AptarGroup with a new price target
- AptarGroup Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery
- New insider Ackerman Daniel claimed ownership of 32,779 shares (SEC Form 3)
- AptarGroup Inc. filed SEC Form 8-K: Leadership Update
- Chief Human Resources Officer Vinczeller Shiela sold $99,733 worth of shares (765 units at $130.37), decreasing direct ownership by 3% to 26,313 units (SEC Form 4)
- President and CEO Touya Gael was granted 2,637 shares, increasing direct ownership by 9% to 31,739 units (SEC Form 4)
- AptarGroup Inc. filed SEC Form 8-K: Leadership Update
- Segment Pres., CEO Designate Touya Gael sold $500,276 worth of shares (3,740 units at $133.76), decreasing direct ownership by 11% to 29,102 units (SEC Form 4)
Latest NCL
- SEC Form 8-K filed by Northann Corp.
- SEC Form 3 filed by Northann Corp.
- SEC Form 8-K filed by Northann Corp.
- Northann Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Northann Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Registrant's Certifying Accountant
- SEC Form 3 filed by new insider Vachon Francois
- Amendment: Northann Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits
- Northann Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- SEC Form NT 10-Q filed by Northann Corp.
- Northann Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Registrant's Certifying Accountant, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Leadership Update, Financial Statements and Exhibits